Healthcare costs and health outcomes analysis of neoadjuvant Trastuzumab therapy for human epidermal growth factor receptor 2 (HER2) positive breast cancer
- Amirhossein Jalali
- , Shirin Moghaddam
- , Andrew McGuire
- , Doireann P. Joyce
- , Bridget Carr
- , Diarmuid O'Leary
- , Emer Bourke
- , Ciaran O'Neill
- , Michael J. Kerin
- , Paddy Gillespie
- , James A.L. Brown
- University of Galway
- University Hospitals Limerick
- Queen's University Belfast
Research output: Contribution to journal › Article › peer-review